Puma Biotechnology Inc is a Los Angeles-based biopharmaceutical firm dedicated to advancing cancer care globally. It specializes in developing innovative treatments, with a keen focus on breast cancer and HER2 mutation-positive solid tumors. Its flagship product, neratinib, is available in both oral and intravenous forms, targeting early stage to advanced HER2-positive breast cancer. Founded in 2010, Puma Biotechnology has formed strategic partnerships with several international companies, including Pfizer, to expand its reach and impact in the fight against cancer.
There’s a small portion of my portfolio I allocate toward companies I’d put in the “higher risk” bucket. For me, that means small caps and companies that trade either under the radar…
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with…
Lee Jackson Tuesday's top analyst upgrades and downgrades included Applied Materials, Aurora Cannabis, Chewy, Coinbase Global, Kinder Morgan, Macy's, Qualcomm and Wells Fargo.
Puma Biotechnology shares made a handy gain early on Thursday after the company presented updated results from its Phase 2 Summit clinical trial of neratinib at the 2019 San Antonio Breast Cancer…
Chris Lange Friday's top analyst upgrades and downgrades included Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon Athletica, Sage Therapeutics, Target, Tesla, Trade Desk and Yext.
Tuesday's top analyst upgrades, downgrades and initiations included Apollo Global Management, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target and TJX Companies.
Puma Biotechnology shares jumped early Wednesday after FDA news about Puma’s breast cancer treatment. However, Puma shares quickly fell off from this FDA sugar high.
Chris Lange Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced to see…
General Electric, Encana Energy, Puma Biotechnology, and Kraft Heinz all posted new 52-week lows Friday.
Stocks were indicated to open higher on China trade deal hopes and after a stronger nonfarm payrolls report. While the stock market has bounced handily from the lows at the end…
Puma Biotechnology shares were climbing on Tuesday after the company announced that it expects a positive outcome in Europe.
Chris Lange The top analyst upgrades, downgrades and other research calls from Friday included AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp and Sarepta Therapeutics.
The world of biotech can be a rags-to-riches story for companies that build up a drug candidate and secure FDA approval for that drug. And the larger the drug target group is,…
Jon C. Ogg The top analyst upgrades, downgrades and other research calls from Thursday include Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp and Southwest Airlines.
Puma Biotechnology saw its shares take a dive on Wednesday following regulatory events in Europe for its breast cancer treatment.
Chris Lange 
